Pacira Pharmaceuticals, Inc.

FDA Drug Class II Ongoing

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65

June 12, 2024 Pacira Pharmaceuticals, Inc. 40,517 kits units

FDA Drug Class II Ongoing

Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-

May 7, 2024 Pacira Pharmaceuticals, Inc. 43,768 kits units

FDA Drug Class II Terminated

EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,

November 21, 2019 Pacira Pharmaceuticals, Inc. 910 20 mL vials units

FDA Drug Class II Terminated

EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufact

December 17, 2012 Pacira Pharmaceuticals, Inc. 324 vials units